ABOUT

THE K-CONNECT PLATFORM

Building the Future of Precision Oncology​

The K-CONNECT Platform is a regional collaborative initiative dedicated to bridging the gap between cutting-edge genomic technology and expert clinical practice. Since its inception, and expanding through 2025 and2026, the platform has matured into a premier ecosystem, earning the endorsement and active support of topAsia-Pacific (APAC) oncologists and healthcare leaders.

A Bridge from Innovation to Impact

At its core, K-CONNECT serves as a vital link between the laboratory and the clinic. While technology evolves at arapid pace, the platform ensures that these advancements—particularly in multi-omics and ArtificialIntelligence—are translated into structured, real-world oncology practices that directly benefit patients.

Looking Toward the Horizon

As K-CONNECT continues to evolve beyond 2026, it remains focused on integrating molecular data into theentire patient journey. From routine screening and early detection to long-term monitoring, the platform isempowering the APAC medical community to deliver a new era of personalized, data-driven oncology.

K-CONNECT 2025 INITIAL ACTIVITIES: 

SCIENTIFIC UPDATES AND KNOWLEDGE SHARING

K-CONNECT 2025 Meeting

An academic event in Da Nang, Vietnam, to foster collaboration and knowledge sharing among oncologists in the Asia-Pacific region.

Online Resources

The K-CONNECT Online Hub provides resources for oncologists, researchers, and healthcare professionals across the region, including MRD, genomic profiling applications, and case studies.

Webinars

A series of webinars for knowledge sharing, covering the latest advancements in cancer treatment and emerging technologies in precision medicine.

COLLABORATION AND CLINICAL TRIALS

Experiencing MRD

A series of collaborations to improve healthcare access, advance medical research, and strengthen the industry's commitment to social good.

Clinical Trials Support

Tailored support for applicants, including:

  • Genomic profiling assays
  • ctDNA monitoring assays
  • Novel biomarker findings

K-CONNECT APAC 2025